Dr. med. Manuela Schöb
Endokrinologie | Diabetologie | Osteologie | Stoffwechselerkrankungen · Dept. I
Safety Outcomes of Impact Microindentation: A Prospective Observational Study in the Netherlands.
Schöb M, Avci T, Winter E, Appelman-Dijkstra N. Safety Outcomes of Impact Microindentation: A Prospective Observational Study in the Netherlands. JBMR Plus 2023; 7:e10799.
Jul 21, 2023Safety Outcomes of Impact Microindentation: A Prospective Observational Study in the Netherlands.
Jul 21, 2023JBMR Plus 2023; 7:e10799
Schöb Manuela, Avci Telli M, Winter Elizabeth M, Appelman-Dijkstra Natasha M
Bone material strength index as measured by in vivo impact microindentation is normal in subjects with high-energy trauma fractures.
Schöb M, Winter E, Malgo F, Schipper I, van der Wal R, Papapoulos S, Appelman-Dijkstra N. Bone material strength index as measured by in vivo impact microindentation is normal in subjects with high-energy trauma fractures. Osteoporos Int 2022; 33:1511-1519.
Mar 21, 2022Bone material strength index as measured by in vivo impact microindentation is normal in subjects with high-energy trauma fractures.
Mar 21, 2022Osteoporos Int 2022; 33:1511-1519
Schöb Manuela, Winter Elizabeth M, Malgo Frank, Schipper I B, van der Wal R J P, Papapoulos S E, Appelman-Dijkstra Natasha M
Bone Material Strength Index as Measured by Impact Microindentation is Low in Patients with Primary Hyperparathyroidism
Schöb M, Winter E, Sleddering M, Lips M, Schepers A, Snel M, Appelman-Dijkstra N. Bone Material Strength Index as Measured by Impact Microindentation is Low in Patients with Primary Hyperparathyroidism. J Clin Endocrinol Metab 2021; 106:e2527-e2534.
Jan 16, 2021Bone Material Strength Index as Measured by Impact Microindentation is Low in Patients with Primary Hyperparathyroidism
Jan 16, 2021J Clin Endocrinol Metab 2021; 106:e2527-e2534
Schöb Manuela, Winter Elizabeth M, Sleddering Maria A, Lips Mirjam A, Schepers Abbey, Snel Marieke, Appelman-Dijkstra Natasha M
High Risk of Hypophosphatemia in Patients with Previous Bariatric Surgery Receiving Ferric Carboxymaltose: A Prospective Cohort Study
Schöb M. High Risk of Hypophosphatemia in Patients with Previous Bariatric Surgery Receiving Ferric Carboxymaltose: A Prospective Cohort Study. Obes Surg 2020; (30/7):2659-2666.
Jul 10, 2020High Risk of Hypophosphatemia in Patients with Previous Bariatric Surgery Receiving Ferric Carboxymaltose: A Prospective Cohort Study
Jul 10, 2020Obes Surg 2020; (30/7):2659-2666
Schöb Manuela
Treatments of osteoporosis increase bone material strength index in patients with low bone mass
Schöb M, Malgo F, Peeters J, Winter E, Papapoulos S, Appelman-Dijkstra N. Treatments of osteoporosis increase bone material strength index in patients with low bone mass. Osteoporos Int 2020
Apr 8, 2020Treatments of osteoporosis increase bone material strength index in patients with low bone mass
Apr 8, 2020Osteoporos Int 2020
Schöb Manuela, Malgo F, Peeters J J M, Winter E M, Papapoulos S E, Appelman-Dijkstra N M
Added Value of Impact Microindentation in the Evaluation of Bone Fragility: A Systematic Review of the Literature
Schöb M, Hamdy N, Malgo F, Winter E, Appelman-Dijkstra N. Added Value of Impact Microindentation in the Evaluation of Bone Fragility: A Systematic Review of the Literature. Front Endocrinol (Lausanne) 2020; 11:15.
Feb 7, 2020Added Value of Impact Microindentation in the Evaluation of Bone Fragility: A Systematic Review of the Literature
Feb 7, 2020Front Endocrinol (Lausanne) 2020; 11:15
Schöb Manuela, Hamdy Neveen A T, Malgo Frank, Winter Elizabeth M, Appelman-Dijkstra Natasha M
[Diagnosis and Treatment of Familial Hypercholesterolemia]
Schöb M, Müller P, Gerth Y, Korte W, Rickli H, Brändle M, Bärlocher A, Bilz S. [Diagnosis and Treatment of Familial Hypercholesterolemia]. Praxis (Bern 1994) 2018; 107:1345-1353.
Nov 1, 2018[Diagnosis and Treatment of Familial Hypercholesterolemia]
Nov 1, 2018Praxis (Bern 1994) 2018; 107:1345-1353
Schöb Manuela, Müller Pascal, Gerth Yannick, Korte Wolfgang, Rickli Hans, Brändle Michael, Bärlocher Andreas, Bilz Stefan
Harmlose blaue Flecken? Gerinnungsstörung trotz normaler INR
Greuter L, Schöb M, Lehmann T, Diethelm M. Harmlose blaue Flecken? Gerinnungsstörung trotz normaler INR. Praxis (Bern 1994) 2014; 103:899-902.
Jul 23, 2014Harmlose blaue Flecken? Gerinnungsstörung trotz normaler INR
Jul 23, 2014Praxis (Bern 1994) 2014; 103:899-902
Greuter Ladina, Schöb Manuela, Lehmann Thomas, Diethelm Markus
Incomplete reporting of baseline characteristics in clinical trials: an analysis of randomized controlled trials and systematic reviews involving patients with chronic low back pain
Wertli M, Schöb M, Brunner F, Steurer J. Incomplete reporting of baseline characteristics in clinical trials: an analysis of randomized controlled trials and systematic reviews involving patients with chronic low back pain. PloS one 2013; 8:e58512.
Mar 7, 2013Incomplete reporting of baseline characteristics in clinical trials: an analysis of randomized controlled trials and systematic reviews involving patients with chronic low back pain
Mar 7, 2013PloS one 2013; 8:e58512
Wertli Maria M, Schöb Manuela, Brunner Florian, Steurer Johann